Company Filing History:
1 out of 10,754 
1 out of 84 Years Active: 1996
Title: Vera Helbl: Innovator in Transcriptional Modulation
Introduction
Vera Helbl is a distinguished inventor based in Fuerth, Germany. She has made significant contributions to the field of molecular biology, particularly in the area of transcriptional regulation. Her innovative work has led to the development of novel methods for controlling gene expression in eukaryotic cells.
Latest Patents
Vera Helbl holds a patent for "Tetracycline regulated transcriptional modulators with altered DNA." This patent discloses isolated nucleic acid molecules encoding fusion proteins that regulate transcription in eukaryotic cells. The fusion proteins include a Tet repressor with at least one amino acid mutation, enabling it to bind to a class B tet operator sequence with specific nucleotide substitutions. The patent also outlines methods for regulating transcription of a tet operator-linked gene by modulating tetracycline concentrations in the cell.
Career Highlights
Throughout her career, Vera has worked with prominent companies such as BASF Aktiengesellschaft and Knoll Aktiengesellschaft. Her experience in these organizations has allowed her to refine her expertise in molecular biology and patent development.
Collaborations
Vera has collaborated with notable scientists, including Hermann Bujard and Manfred Gossen. These partnerships have contributed to her innovative research and advancements in transcriptional modulation.
Conclusion
Vera Helbl's contributions to the field of molecular biology and her innovative patent on transcriptional modulators highlight her role as a leading inventor. Her work continues to influence the scientific community and pave the way for future advancements in gene regulation.